- Home
- AMS vs OVID Comparison
AMS vs OVID Comparison
Compare AMS & OVID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMS
- OVID
- Stock Information
- Founded
- AMS 1980
- OVID 2014
- Country
- AMS United States
- OVID United States
- Employees
- AMS N/A
- OVID N/A
- Industry
- AMS Medical Specialities
- OVID Biotechnology: Pharmaceutical Preparations
- Sector
- AMS Health Care
- OVID Health Care
- Exchange
- AMS Nasdaq
- OVID Nasdaq
- Market Cap
- AMS 17.2M
- OVID 20.6M
- IPO Year
- AMS N/A
- OVID 2017
- Fundamental
- Price
- AMS $2.48
- OVID $0.56
- Analyst Decision
- AMS
- OVID Strong Buy
- Analyst Count
- AMS 0
- OVID 4
- Target Price
- AMS N/A
- OVID $3.13
- AVG Volume (30 Days)
- AMS 4.2K
- OVID 2.4M
- Earning Date
- AMS 08-13-2025
- OVID 08-19-2025
- Dividend Yield
- AMS N/A
- OVID N/A
- EPS Growth
- AMS 151.01
- OVID N/A
- EPS
- AMS 0.21
- OVID N/A
- Revenue
- AMS $29,236,000.00
- OVID $548,000.00
- Revenue This Year
- AMS $9.95
- OVID N/A
- Revenue Next Year
- AMS N/A
- OVID $5.32
- P/E Ratio
- AMS $11.97
- OVID N/A
- Revenue Growth
- AMS 35.25
- OVID 15.61
- 52 Week Low
- AMS $2.27
- OVID $0.24
- 52 Week High
- AMS $4.60
- OVID $1.47
- Technical
- Relative Strength Index (RSI)
- AMS 46.12
- OVID 60.35
- Support Level
- AMS $2.46
- OVID $0.48
- Resistance Level
- AMS $2.54
- OVID $0.73
- Average True Range (ATR)
- AMS 0.09
- OVID 0.05
- MACD
- AMS -0.01
- OVID -0.01
- Stochastic Oscillator
- AMS 22.22
- OVID 31.16
About AMS American Shared Hospital Services
American Shared Hospital Services provides stereotactic radiosurgery equipment, Advanced radiation therapy, and related equipment. It currently provides Gamma Knife units to medical centers and stand-alone facilities. The company, along with its subsidiaries, operates through the following operations: Gamma Knife, Advanced Radiation Therapy Equipment and Services, and Proton Beam Radiation Therapy Operations. It generates most of its revenue from the domestic market.
About OVID Ovid Therapeutics Inc.
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.